Wed Sep 18 00:53:45 UTC 2024: ## Paysign CEO Sells Shares Amidst Strong Q2 Earnings and Growth Plans

**Henderson, Nevada – September 14, 2024** – Paysign, Inc. (NASDAQ: PAYS) CEO Mark Newcomer recently sold 1,500 shares of the company’s stock, according to filings. The transaction, which occurred on September 13th, was executed under a pre-determined trading plan adopted in June, aimed at preventing potential insider trading accusations. Despite the sale, Newcomer still holds a substantial stake in Paysign.

The news of the insider transaction comes as Paysign reported strong Q2 2024 earnings, with revenue surging 30% year-over-year to $14.3 million. This growth was driven primarily by the company’s patient affordability business, which saw a remarkable 267% revenue increase. The company’s adjusted EBITDA also rose significantly, reaching $2.24 million, a 96% jump from the previous year.

Fueled by this robust performance, Paysign has revised its full-year revenue guidance upwards, now expecting revenues between $56.5 million and $58.5 million. The company plans to further expand its plasma donor compensation business by adding 5 to 10 new plasma centers by year’s end.

Despite a high valuation and expected decline in net income this year, Paysign’s stock has seen a remarkable 124% price total return over the past year, indicating strong investor confidence. The company’s robust revenue growth, with a 26.45% increase over the past twelve months and a healthy gross profit margin of 52.22%, further supports this sentiment.

Investors are closely monitoring Paysign’s financial metrics and market performance following the CEO’s stock sale. While some may view the sale as a potential negative signal, others see it as a planned transaction under a pre-determined schedule. The company’s future prospects remain bright, with a growing client base and expansion plans across various sectors.

Read More